Results showed that DKK3 expression was restored in response to 5-aza-dC treatment, along with increased unmethylated promoter alleles (Fig. 1D), suggesting that promoter methylation is directly responsible for DKK3 down-regulation in breast cancer cells. This evidence concerns the gene DKK3 and breast carcinoma.